From where we were at the beginning, it is massive improvements, and the more people that join the study, the better it’s going to get.” ...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical trials. The company said it is using organoids – small ...

Quantum computing has been lurking in the background for years. Discover 5 cutting-edge science sectors like CRISPR and ...